A Comparison of Innovative Treatments for Obesity and Type 2 Diabetes
In recent years, the medical community has made significant strides in the treatment of obesity and type 2 diabetes, two interconnected conditions that affect millions of people worldwide. Among the most promising developments are two medications: Tirzepatide and Semaglutide. Both are glucagon-like peptide-1 (GLP-1) receptor agonists, but they have